From the Kansas City Court Report
The legal report underscored a crucial point: "In its press release announcing emergency use authorisation for its COVID-19 vaccine, Pfizer did not disclose that it had excluded immunocompromised individuals from its COVID-19 vaccine trials.”
Instead, in “Important Safety Information” in its press release, Pfizer noted that
“[i]mmunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the Pfizer BioNTech COVID-19 Vaccine.”
